Home › Targets › GLP-1
GLP-1 (5 companies · 9 programs)
Companies with an active program directed at GLP-1.
- MBX 4291 — Obesity Phase 1
- MBX 5765 — Obesity Preclinical
- MBX 6180 — Obesity Preclinical
- VK2735 — Obesity Phase 3
- VK2735 — Obesity Phase 2
- VK2735 — Type 2 Diabetes Phase 1
- pemvidutide — Alcohol Use Disorder Phase 2
- oral oxyntomodulin — Obesity Preclinical
- Vyleesi — Obesity Phase 2